Johnson and Johnson VS Sanofi

NOTE:
Ratio Template
Fall 2013 - Johnson & Johnson (J&J)
($ in millions except per sh)

These are Input Cells - Enter your information here.

These are Ratio Formula Cells - Your ratios will automatically update
here as you key in your data to the Input Cells.
Note: The first column is for J&J's fiscal year 2012, which ended
12/30/2012 (date on the Balance Sheet).
These are cells that should NOT have data in them.

Financial Statement Balances:

J&J - FY'12

Balance Sheet
Cash
Marketable Securities
Net A/R
Inventory
Total Current Assets
Net PP&E (fixed assets)
Total Assets
A/P
Total Current Liabilities
Total Liabilities
Total Stockholders' Equity

($ in millions)
14,911.0
6,178.0
11,309.0
7,495.0
46,116.0
16,097.0
121,347.0
5,831.0
24,262.0
56,521.0
64,826.0

J&J - FY'11

J&J - FY'10

($ in millions) ($ in millions)
24,542.0
19,355.0
7,719.0
8,303.0
10,581.0
9,774.0
6,285.0
5,378.0
54,316.0
47,307.0
14,739.0
14,553.0
113,644.0
102,908.0
5,725.0
5,623.0
22,811.0
23,072.0
56,564.0
46,329.0
57,080.0
56,579.0

SNY FY'12

SNY FY'11

SNY FY'10

($ in millions) ($ in millions) ($ in millions)

8809.0
5693.2
8924.9 *Data from
7379.7
4170.2
7773.2 http://www.marketwatch.com/investing/stock/jnj
10363.4
11102.0
8982.9 http://www.marketwatch.com/investing/stock/sny
8596.4
8153.1
6764.0 https://www.jnj.com/sites/default/files/pdf/JNJ2012annualreport.pdf
30720.7
28013.8
27005.9 http://en.sanofi.com/investors/events/corporate/2013/2013-02-07_Results_2012.aspx
14252.8
14484.6
10988.1
135288.4
134962.3
114884.7 *Note I did convert Euros to US Dollars
4298.2
4288.8
3772.7
18675.0
18276.1
13591.2
57799.4
58956.8
40831.6 *Vertical and Horizontal Analysis on Sheet 2
79340.1
77822.9
73564.1

Income Statement
Net Sales/Revenue
Cost of Good Sold
Gross Profit
Operating Income/Profit
Earnings before taxes
Net Income/Profit
Interest Expense

67,224.0
21,658.0
45,566.0
15,869.0
13,775.0
10,853.0
532.0

65,030.0
20,360.0
44,670.0
16,153.0
12,361.0
9,672.0
571.0

61,587.0
18,792.0
42,795.0
16,527.0
16,947.0
13,334.0
455.0

38900.8
11801.9
28356.0
12825.9
8538.5
6920.3
667.0

44988.3
14688.3
32547.8
7721.4
7166.8
7995.5
602.3

43611.3
12661.9
33197.2
8804.6
8317.5
7708.5
638.7

Stmt. Of Cash Flows

Cash from Operating (CFO)
Cash from Investing (CFI)
Capital Expenditures

15,396.0
(4,510.0)
(2,934.0)

14,298.0
(4,612.0)
(2,893.0)

16,385.0
(7,854.0)
(2,384.0)

11008.3
-2142.4
-2172.0

12556.4
-19808.1
-2399.7

13284.0
-4682.2
-2239.4

Other Information:
Divi. PER C/sh (St S/E or Notes)
2.40
2.25
2.11
2.8
2.7
Dividends (total per St S/E)
6,614.00
6,156.00
5,804.00
4698.4
1848.6
Days
365
365
365
365.0
365.0
Market Price PER C/sh at FY end
69.48
65.58
61.85
62.8
49.8
EPS (Basic) (from I/S)
3.94
3.54
4.85
3.7
3.4
(Note: The fiscal year end C/S (common stock) price can be found on several different websites, including
www.marketwatch.com. After keying in the stock symbol, hit enter, which will then give you an option for
"historical quotes". Key in the fiscal year end date and select the "closing price".)
RATIOS:
Current Ratio
Quick Ratio
Average Collection Period
Average days in Inventory
Days Payable Outstanding
Cash conversion cycle
A/R Turnover
Inventory Turnover
Fixed Asset Turnover
Total Asset Turnover
Return on Assets
Debt Ratio
Debt to Equity
Financial Leverage
Times Interest Earned
Free cash flow
Cash Flow Adequacy
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Cash flow to Net Income
Cash Return on Assets
Return on Equity
Earnings per C/S (EPS)
Price Earnings Ratio (PE)
Dividend Payout Ratio
Dividend Yield
Growth Rate for Cash
Growth Rate for Total Assets
Growth Rate for Marketable Securtity

1.90
1.34
59
116
98
77
6.14
3.14
4.36
0.57
9.24%
46.58%
0.87
1.81
26.89
10,886.00
5.25
67.78%
23.61%
16.14%
1.42
13.10%
17.81%
3.94
17.63
60.94%
3.45%
-39.24%
6.78%
-19.96%

2.38
1.88
57
105
103
59
6.39
3.49
4.44
0.60
8.93%
49.77%
0.99
1.90
22.65
9,686.00
4.94
68.69%
24.84%
14.87%
1.48
13.21%
17.02%
3.54
18.53
63.65%
3.43%
26.80%
10.43%
-7.03%

2.05
1.62

45.02%
0.82
38.25
8,531.00
6.87
69.49%
26.84%
21.65%
1.23

4.85
12.75
43.53%
3.41%

1.65
1.40
81
204
105
181
4.50
1.79
3.28
0.35
5.11%
42.69%
0.73
1.75
12.87
6,584.00
5.07
71.08%
18.13%
14.79%
1.59
8.13%
9.02%
3.65
16.97
67.89%
4.41%
54.73%
-0.26%
76.96%

1.53
1.13
80
185
107
159
4.48
1.97
3.53
0.36
6.38%
43.98%
0.79
1.65
12.90
-5,382.00
5.23
72.35%
17.16%
17.77%
1.57
10.02%
10.56%
3.40
14.65
23.12%
5.30%
-36.21%
18.07%
-46.35%

1. You should do a Common Size Balance Sheet and Common Size Income Statement to provide additional ratios
for comparing your companies (vertical analysis).
2. You should do additional growth rates on whichever line items you feel would provide additional insight for analysis.
NOTE: You will need to key in your own formulas for the growth rates, depending on which line items you are
analyzing (horizontal analysis).

2.5
4218.7
365.0
51.5
3.3

1.99
1.86

35.54%
0.57
14.02
6,384.00
5.93
76.12%
20.19%
17.68%
1.72

3.34
15.41
54.73%
4.85%